Research Interests

The Centre's Board and Steering Groups are comprised of a wide range of individuals in our Partner organsiations, who form the basis of the Centre's clinical and non-clinical & basic science research interests, listed below.

A large selection of potential project titles is also available for development in to competive fellowship applications with Centre affiliated academic supervisors. Contact us if you think your skills and research experience match a particular title.



Research areas


Professor David Lalloo

Clinical trials in resource poor settings; travel medicine.
He has focused on clinical trials in the tropics, particularly in HIV related infections, malaria and envenoming. He currently has collaborations and studies in a number of countries including Uganda, Malawi, Sri Lanka and Vietnam.


Professor Neil French

Bacterial disease, the interaction with HIV and prevention by vaccination. Although best described as a clinical epidemiologist he works with a broad array of research disciplines to promote vaccine development and policy.


Professor Andy Waters

Understanding the molecular basis underpinning the commitment to sexual development in Plasmodium and the establishment of polarity in the fertilised zygote.

A focus on understanding how drugs work against parasites and how parasites become resistant to drugs.



Dr Annette MacLeod

The interaction between parasites, African trypanosomes, and their hosts, bridging the gap between field based population studies, genomics, and lab-based molecular biology, with a long-term view to exploiting these interactions to combat disease.


Professor Paul Garside

The long standing theme of my research has been to investigate the fundamentals of immune regulation in vivo and apply any findings to infectious and autoimmune disease scenarios. A key aspect has been my partnership with Prof Jim Brewer as we have continued to drive innovative approaches to understanding immune responses in vivo.


Professor Andrew Weeks

I have a special interest in maternal mortality in the developing world, clinical trials, the management of labour and delivery, and misoprostol use. Between 2000 and 2002 I worked as a visiting clinical lecturer in obstetrics at Makerere University, Kampala, Uganda researching low technology methods for reducing maternal mortality. This included misoprostol for incomplete miscarriage and umbilical oxytocin injection for retained placenta.





Professor Janneke van de Wijgert

I am a translational infectious disease researcher with public health, clinical and lab experience. The focus of my research is the role of the human microbiome and mucosal immunology in reproductive, maternal and neonatal health, and transmission of HIV and other sexually transmitted infections (STIs). This includes intervention studies in resource-limited settings, such as clinical trials of novel technologies to prevent HIV acquisition or pre-term births in women, and improvement of reproductive health care.



Professor Alister Craig


Malaria pathogenesis; cytoadherence; endothelial dysfunction


Professor Nigel Cunliffe

Diagnosis, treatment and prevention of paediatric gastroenteritis using methods that include molecular diagnostics, clinical trials and disease surveillance. My current focus is the prevention of rotavirus gastroenteritis by vaccination.



Professor Stephen Gordon

Susceptibility to lung infection, pneumococcal disease and inhaled vaccines. Household air pollution and lung diseases. Capacity building in medical research in Africa.



Hot water epilepsy, genetics of epilepsy, progressive myoclonic epilepsy & neuro infection including neuro AIDS.


Professor S Bertel Squire

Clinical and public health aspects of tuberculosis.

Applied health research to improve equity in access to health services.


Dr Sally Theobald

I have a disciplinary background of geography and development studies and a PhD in Gender, Health and Development. I have wide ranging experience of designing and implementing gender sensitive qualitative research projects on HIV, TB, SRH and health systems in Africa and Asia.


Professor Enitan Carrol


Childhood bacterial infections, Improving diagnosis of bacterial infection, host response to bacterial infections, early warning scores to predict deterioration


Professor Nynke van den Broek


Maternal and newborn health in developing countries, maternal health and pregnancy outcome, quality of care and strengthening the capacity of healthcare providers to provide skilled birth attendance and essential obstetric care.



Professor Steve Ward

Drug discovery, drug development and tropical pharmacology. Understanding the chemical, molecular and cellular basis of drug action and drug resistance in tropical pathogens with an emphasis on human malaria, TB and more recently the Neglected Tropical Diseases (NTDs).





Professor Tom Solomon


My group studies neurological infections, much of our work is on improved diagnostics and disease mechanisms, to improve outcomes, but our projects range from the basic biology, through clinical studies to public health and programmatic implementation. We are particularly interested in emerging infections like Japanese encephalitis and enteroviruses 71 in Asia (especially India, Nepal, Malaysia), but we also study HIV brain disease in Malawi, and have more recently started research on bacterial brain infections.



Dr Melita Gordon

My research interest centres around invasive Salmonella disease in adults and children, both typhoidal and non-typhoidal. My research uses multiple clinical, statistical and laboratory methodologies to study epidemiology and transmission, bacterial phylogenomics, clinical presentation and clinical pathogenesis, the host cellular and molecular inflammatory response, the humoral and cellular immune responses to both infection and vaccination, and gut mucosal cellular responses to vaccination.



Professor Saye Khoo

Research focuses on the pharmacology of HIV treatment failure and how therapy may be improved through individualised care through understanding of why drug exposure varies markedly between individuals (and the role of individual characteristics such as weight, gender, host genetics and drug interactions), and identify vulnerable groups who are at particular risk of failure, or toxicity.


Professor Aras Kadioglu

My primary research interests are on pathogenesis of Streptococcus pneumoniae, and its interactions with innate and adaptive immunity during nasopharyngeal carriage and invasive disease. Group A Streptococcus and Pseudomonas aeruginosa are other areas of study.



Professor Sarah O’Brien


Personal research interests include unravelling the epidemiology of infectious diseases and understanding the contribution of acute infection to chronic illness.